文献
J-GLOBAL ID:202202271291106714
整理番号:22A0702768
現代治療で治療したFMS様チロシンキナーゼ3内部タンデム重複変異急性骨髄性白血病の新たに診断された患者の転帰改善:欧州白血病ネット有害リスク分類の再検討【JST・京大機械翻訳】
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification
著者 (18件):
Reville Patrick K.
(Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Sasaki Koji
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Kantarjian Hagop M.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Daver Naval G.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Yilmaz Musa
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Dinardo Courtney D.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Short Nicholas J.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Borthakur Gautam
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Pemmaraju Naveen
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Mehta Rohtesh S.
(Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Pierce Sherry
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Konoplev Sergej N.
(Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Khoury Joseph D.
(Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Garcia-Manero Guillermo
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Konopleva Marina Y.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Jabbour Elias
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Ravandi Farhad
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
,
Kadia Tapan M.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA)
資料名:
American Journal of Hematology
(American Journal of Hematology)
巻:
97
号:
3
ページ:
329-337
発行年:
2022年
JST資料番号:
E0721B
ISSN:
0361-8609
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)